Filter
11358
Filtered Results: 11358
Text search:
disease
control
Featured
Recommendations
1047
New Publications
2709
Language
Document type
No document type
5845
Studies & Reports
1788
Guidelines
1698
Manuals
526
Fact sheets
439
Strategic & Response Plan
382
Training Material
181
Infographics
121
Situation Updates
117
Resource Platforms
117
Online Courses
59
Brochures
45
Videos
26
Dashboards/Maps
12
App
2
Countries / Regions
Global
547
India
465
Sierra Leone
281
Kenya
267
Liberia
242
Western and Central Europe
230
Africa
230
Nigeria
223
South Africa
220
Ethiopia
209
Latin America and the Carribbean
197
Uganda
177
Congo, Democratic Republic of
168
Nepal
167
Rwanda
140
Guinea
134
Malawi
128
West and Central Africa
126
Tanzania
125
Syria
119
Bangladesh
118
Ghana
114
Zambia
113
Senegal
112
Mozambique
112
Myanmar / Burma
109
Middle East and North Africa
109
East and Southern Africa
99
Russia
99
Ukraine
95
Brazil
91
South Sudan
90
Haiti
87
Eastern Europe
83
Burkina Faso
82
Philippines
79
Yemen
76
Germany
74
Namibia
71
South–East Asia Region
65
Zimbabwe
61
Mali
58
Indonesia
58
Colombia
58
Asia
57
Côte d’Ivoire / Ivory Coast
53
Cameroon
52
Lesotho
51
Guinea-Bissau
50
Cambodia
50
Venezuela
50
Angola
49
Eastern Europe and Central Asia
45
Paraguay
38
Chad
37
Botswana
35
Niger
29
Eswatini/ Swaziland
29
Madagascar
29
Benin
28
Argentina
28
Pakistan
27
Sudan
27
USA
25
Peru
25
Chile
25
Western Pacific Region
25
Central African Republic
24
Ecuador
24
Somalia
23
Afghanistan
23
Bolivia
23
Vietnam
20
Spain
19
China
18
Iraq
16
Thailand
16
North America
15
Tajikistan
14
Jordan
13
Albania
13
Togo
12
Lebanon
12
Moldova
12
Saudi Arabia
10
Egypt
10
Portugal
10
Mexico
9
Sri Lanka
9
Italy
9
Laos
9
Georgia
9
Turkey
8
Papua New Guinea
8
Burundi
8
El Salvador
8
Palestine
8
Southern Africa
8
North Macedonia
7
Honduras
7
Libya
6
Armenia
6
Timor Leste/ East Timor
6
Iran
6
Kazakhstan
6
France
6
Gambia
5
Bhutan
5
Poland
5
Djibouti
5
Romania
5
Uruguay
5
United Kingdom
5
Malaysia
4
Hungary
4
Congo-Brazzaville
4
Canada
4
Kyrgyzstan
4
Turkmenistan
4
Japan
4
Belarus
4
Mauritania
3
Singapore
3
Dominican Republic
3
Serbia
3
Greece
3
Guatemala
3
Fiji
3
North Korea
3
Uzbekistan
3
Gabon
3
Jamaica
3
Mauritius
3
Tunisia
3
Morocco
2
Ireland
2
Other region
2
Qatar
2
Bulgaria
2
Estonia
2
Slovakia
2
Belgium
2
South Korea
2
Israel
2
Bosnia and Herzegovina
2
Vanuatu
1
Austria
1
Switzerland
1
Cuba
1
Cape Verde
1
Nicaragua
1
Solomon Islands
1
Mongolia
1
Lithuania
1
Australia
1
Denmark
1
Maldives
1
Morocco
1
Azerbaijan
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
4041
Clinical Guidelines
929
Public Health
712
Key Resources
451
Women & Child Health
400
Capacity Building
190
Pharmacy & Technologies
138
Annual Report MEDBOX
2
Toolboxes
COVID-19
1553
HIV
713
Mental Health
698
TB
691
Ebola
620
NTDs
453
Rapid Response
450
AMR
401
NCDs
353
Planetary Health
352
Caregiver
260
Conflict
197
Zika
191
Refugee
184
Disability
183
Pharmacy
161
Global Health Education
149
Cholera
144
Natural Hazards
118
Health Financing Toolbox
90
Polio
71
Specific Hazards
69
Social Ethics
22
Typhoon
4
Health Financing
3
South Sudan
2
Stop TB Communicable Diseases
The previous report of the WHO Expert Committee on this disease
followed a meeting in 1995. Intensive, coordinated efforts against HAT during
the intervening 18 years have resulted in a decrease in incidence to a point at
which elimination is ...
WHO guideline on preventive chemotherapy for public health control of strongyloidiasis
recommended
Human strongyloidiasis is a chronic parasitic disease caused by infection with Strongyloides stercoralis, a soil-transmitted helminth that is estimated to infect 300–600 million people worldwide. This neglected tropical ... (NTD) is endemic globally, predominately in the South-East Asia, African and Western Pacific regions, and in South and Central America. Strongyloidiasis has a wide range of clinical presentations, including subclinical disease, symptomatic disease (often with diarrhoea, abdominal pain and urticaria) and a rare but deadly complication of hyperinfection with disseminated disease. The feared complication of disseminated strongyloidiasis can occur in the setting of immunocompromising conditions (e.g. human T-cell lymphotropic virus type 1 infection and malignancies) or immunosuppressive medications (e.g. steroids) and has an estimated case-fatality rate exceeding 60%. The standard treatment for chronic S. stercoralis infection is oral medication with ivermectin.
Antimicrobials are used in veterinary medicine to treat infectious diseases in animals caused or complicated by microorganisms, mainly bacteria, or to prevent the development or spread of infection in healthy animals.
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, and the collective failure to take the coordinated actions required ...
Together we can Prevent and Control the World's Most Common Diseases
Objectives of the training manual
(1) To improve knowledge of NCD trends, burdens, as well as systems for management and monitoring of NCD services for Township Medical O...
Objectives of the training manual
(1) To improve knowledge of NCD trends, burdens, as well as systems for management and monitoring of NCD services for Township Medical O...
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and ... should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must be added the awareness that schistosomiasis is also a disease of poverty. It still survives in poverty-stricken, remote areas where there is little or no safe water or sanitation, and health care is scarce or non-existent. For a variety of complex reasons, many of which are addressed in this book, the disease is particularly prevalent in sub-Saharan Africa, and persists in certain areas of rural China. This concern for human behaviour in an environment of poverty echoes the concerns of the new research priority for “diseases of poverty” identified by the Special Programme for Research & Training in Tropical Diseases.
Schistosomiasis is widely recognized as a disease that is socially determined. An
understanding of the social and behavioural factors linked to disease transmission and
... should play a vital role in designing policies and strategies for schistosomiasis
prevention and control. To this must be added the awareness that schistosomiasis is
also a disease of poverty. It still survives in poverty-stricken, remote areas where there
is little or no safe water or sanitation, and health care is scarce or non-existent. For
a variety of complex reasons, many of which are addressed in this book, the disease
is particularly prevalent in sub-Saharan Africa, and persists in certain areas of rural
China. This concern for human behaviour in an environment of poverty echoes the
concerns of the new research priority for “diseases of poverty” identified by the
Special Programme for Research & Training in Tropical Diseases.
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis for many national guidelines. However, uptake of existing guidelines is poor. A major revision of the GINA r...
Apart from implementation of TB infection Prevention and Control measures, treatment of those with active TB of the lungs is key in preventing the spread of the TB bacilli. The Public Health Act CAP 242, section 17 classify TB as notifiable infectio...
Methodology for evaluating national national arboviral disease prevention and and control of arboviral diseases in the Americas
Sub-Saharan Africa faces a major public-health challenge from non-communicable diseases. Although infectious diseases continue to afflict Africa, the proportion of the overall ... burden in sub-Saharan Africa attributable to cancer is rising, and the region is predicted to have a greater than 85% increase in cancer burden by 2030. This Series of seven papers focuses on cancer control in Africa, outlining the current situation, detailing barriers to care, and presenting ideas to advance cancer care and control in the region.
Snakebite envenoming is a neglected tropical disease (NTD) that is responsible for enormous suffering, disability and premature death on every continent. As over 5.8 billion people are at risk of encountering a venomous snake, it is not surprising b...
Cutaneous leishmaniasis (CL) is a parasitic disease caused by infection with a vector-borne protozoan parasite of the genus Leishmania spp. The parasite is transmitted by the bite of an infected phlebotomine sand fly. Infection results in skin lesio...
The control and elimination of schistosomiasis have over the last two decades involved several strategies, with the current strategy by the World Health Organization (WHO) focusing mainly on treatment with praziquantel during mass drug administratio...
Malaria is a prevalent cause of febrile illnesses in areas with high transmission, and its clinical presentation overlaps with initial signs of Ebola disease. For this reason, the effectiveness of the Ebola response in Guinea, Liberia and Sierra Leo...
The Sierra Leone National Infection Prevention and Control Guidelines were jointly developed and updated by the Ministry of Health and Sanitation in collaboration with the World Health Organization and the US Centers for ... Control and Prevention.
The Global vector control response 2017–2030 (GVCR) provides a new strategy to strengthen vector control worldwide through increased capacity, improved surveillance, better coordination and integr...
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the ..., and reducing spillover of the virus from animals to humans.
Mpox is a viral illness caused by the monkeypox virus (MPXV). It can cause a painful rash, enlarged lymph nodes and fever. Most people fully recover, but some get very sick. The virus transmits from person to person through close, including sexual, contact. It also has animal reservoirs in east, central and west Africa, where spillovers from animals to humans can occasionally occur, sparking further outbreaks.
There are two different clades of the virus: clade I and clade II. Clade I outbreaks are deadlier than clade II outbreaks.
A major emergence of mpox linked to clade II began in 2017, and since 2022, has spread to all regions of the world. Between July 2022 and May 2023, the outbreak was declared a Public Health Emergency of International Concern. While that outbreak has largely subsided, cases and deaths continue to be reported today, illustrating that low-level transmission continues around the world.
Currently, there is also a major outbreak of clade I virus in the Democratic Republic of the Congo (DRC), where cases have been on the rise for decades. Since the beginning of the year, over 6500 cases and 345 deaths have been reported in the DRC. Almost half of these are among children under the age of 15 years.
The Strategic framework for enhancing prevention and control of mpox (2024–2027) provides a roadmap for health authorities, communities, and stakeholders worldwide to control mpox outbreaks in every context, advance mpox research and access to countermeasures, and to minimize zoonotic transmission.
The major areas of focus for the plan will be:
- Social mobilization and community empowerment (health promotion & education for disease prevention);
- Promotion of access to safe water, good sanitation and hygiene;
- Surveillance an...
- Social mobilization and community empowerment (health promotion & education for disease prevention);
- Promotion of access to safe water, good sanitation and hygiene;
- Surveillance an...
